How to Get Cytomel (Liothyronine) in Arkansas

What Liothyronine (Cytomel) Is and Why Physicians Prescribe It in Arkansas

Liothyronine is the synthetic form of triiodothyronine (T3), the biologically active thyroid hormone that acts directly on nuclear receptors in every tissue. Physicians in Arkansas prescribe it when a patient does not convert levothyroxine (T4) to sufficient T3, or when symptoms persist despite a normal TSH on levothyroxine alone. The FDA approved Cytomel for hypothyroidism, myxedema, and thyroid suppression therapy. Pfizer's Cytomel label is on file with the FDA.

The clinical rationale for adding T3 to T4 therapy gained traction after Bunevicius et al. published a crossover trial in the New England Journal of Medicine showing that a combination of T4 plus T3 improved mood, neuropsychological function, and physical well-being compared with T4 alone in 33 hypothyroid patients. [1] That 1999 trial remains one of the most-cited arguments for combination therapy even though later, larger studies produced mixed results. [2] Patients in Arkansas who report persistent fatigue, cognitive difficulty, or depression despite normal TSH on levothyroxine are exactly the population where a prescribing clinician may reach for liothyronine.

The American Thyroid Association's 2014 guidelines state that "clinicians may consider a trial of combination T4 and T3 therapy in patients who are dissatisfied with their treatment results while taking levothyroxine alone." [3] Arkansas providers follow those guidelines, and many also reference the 2019 updated European Thyroid Association guidance, which supports individualized T3 dosing in selected patients. [4]

Liothyronine's half-life is roughly 24 hours, far shorter than levothyroxine's 6 to 7 days. That shorter half-life means serum T3 peaks one to four hours post-dose and then falls, which is why many clinicians split the daily dose into two administrations. A twice-daily 12.5 mcg regimen produces smaller serum swings than a single 25 mcg morning dose, a point supported by pharmacokinetic data published in the European Journal of Endocrinology. [5]

Arkansas Prescribing Rules: Who Can Write a Liothyronine Script

Any Arkansas-licensed MD, DO, nurse practitioner (NP), or physician assistant (PA) operating within their scope of practice may prescribe liothyronine. Arkansas Code Annotated § 17-87-310 grants advanced practice registered nurses full prescriptive authority with a collaborative practice agreement for schedule and non-schedule drugs, which means NPs at telehealth clinics can legally send a liothyronine prescription to an Arkansas pharmacy. [6] PAs prescribe under a supervision agreement with a collaborating physician per Arkansas Code § 17-105-104.

Endocrinologists write the majority of new liothyronine prescriptions in Arkansas, but primary-care physicians and internists also prescribe it routinely. The University of Arkansas for Medical Sciences (UAMS) Endocrinology clinic in Little Rock is the state's largest academic referral center for complex thyroid disease. Wait times at UAMS can reach 8 to 12 weeks for new patients, which is one reason telehealth has become a practical first stop. [7]

Telehealth providers licensed in Arkansas must comply with Act 788 of 2021, which made Arkansas's telehealth parity law permanent. A clinician who holds an active Arkansas medical license may conduct a synchronous video visit and issue a prescription for liothyronine without requiring a prior in-person examination, provided the standard of care is met. [8] That standard includes a documented thyroid diagnosis, recent labs, and a record of prior thyroid treatment.

Required Labs Before an Arkansas Provider Will Prescribe Liothyronine

A prescribing clinician in Arkansas will order or review the following before initiating liothyronine. Labs must typically be dated within the past 3 to 6 months.

TSH (thyroid-stimulating hormone). The first-line screening test per ATA guidelines. A TSH outside the 0.4, 4.0 mIU/L reference range on levothyroxine therapy is a strong indicator that thyroid hormone replacement needs adjustment. [3]

Free T3 (FT3). A low-normal or below-range Free T3 alongside a normal TSH is the laboratory signature that often prompts a clinician to add liothyronine. Reference ranges vary by laboratory, but most use 2.3, 4.2 pg/mL. [9]

Free T4 (FT4). Needed to confirm that the patient is adequately converting or absorbing levothyroxine. Low FT4 with low FT3 may indicate non-compliance or malabsorption rather than a conversion defect. [9]

Total T3. Some clinicians order Total T3 alongside Free T3 to assess binding-protein effects. The NIH's National Institute of Diabetes and Digestive and Kidney Diseases publishes normal adult Total T3 reference ranges of 80 to 180 ng/dL. [10]

Complete metabolic panel (CMP) and lipid panel. Hypothyroidism elevates LDL cholesterol and liver enzymes. Baseline values help the clinician track therapeutic progress. [11]

Cardiovascular assessment. Because liothyronine can increase heart rate and, at supraphysiologic doses, raise atrial fibrillation risk, clinicians typically obtain a resting heart rate and, in patients over 65 or with existing cardiac disease, an ECG before prescribing. The American Heart Association notes that even subclinical hyperthyroidism (TSH <0.1 mIU/L) doubles atrial fibrillation risk in older adults. [12]

Most Arkansas telehealth platforms integrate with national lab networks (LabCorp or Quest) so patients can complete a draw at a local Arkansas location before their prescribing visit.

How to Get a Liothyronine Prescription in Arkansas: Step-by-Step

Getting liothyronine in Arkansas follows a clear sequence regardless of whether the patient uses an in-person provider or a telehealth clinic.

Step 1. Gather existing records. Collect any prior thyroid labs, a list of current medications (especially levothyroxine dose and brand), and prior diagnosis documents. Prior records compress the clinical visit and reduce the chance of needing a second appointment before prescribing.

Step 2. Choose a care pathway. Three pathways are available in Arkansas: (a) referral to an endocrinologist, (b) primary-care physician consultation, or (c) a licensed telehealth provider. Telehealth is currently the fastest route for most patients without complex thyroid cancer histories.

Step 3. Complete or order labs. If labs are older than 6 months, most providers will require a fresh panel. Arkansas has LabCorp patient-service centers in Little Rock, Fayetteville, Jonesboro, and Fort Smith, among other cities. Quest operates sites in the same metro areas.

Step 4. Attend the clinical visit. The clinician reviews history, labs, symptoms, and current medications. A thorough provider will also screen for contraindications: untreated adrenal insufficiency, recent myocardial infarction, and uncorrected thyrotoxicosis each represent absolute contraindications per the Cytomel prescribing label. [13]

Step 5. Receive the prescription. If the prescriber determines liothyronine is appropriate, they send the prescription electronically to a pharmacy of the patient's choice. Arkansas law permits e-prescribing for non-controlled substances, and liothyronine is not a scheduled drug.

Step 6. Fill at a licensed pharmacy. See the pharmacy section below for options.

Most patients complete steps 1, 5 within one week when using a telehealth platform. UAMS or private endocrinology referrals may take 4 to 12 weeks depending on specialist availability in the patient's region of Arkansas.

Dosing: What Arkansas Clinicians Typically Prescribe

Liothyronine dosing is individualized. The FDA-approved label for Cytomel lists a starting dose of 25 mcg once daily for mild hypothyroidism, with increases of 12.5 to 25 mcg every 1 to 2 weeks until the patient is euthyroid and symptom-free. [13] Most adults stabilize between 25 and 75 mcg per day. Elderly patients and those with cardiovascular disease typically start at 5 mcg once daily and titrate slowly.

When liothyronine is added to existing levothyroxine therapy, the levothyroxine dose is usually reduced by 50 mcg for every 12.5 mcg of T3 added. That 4:1 T4-to-T3 substitution ratio approximates the relative potency difference between the two hormones. A 2019 randomized trial published in The Lancet Diabetes and Endocrinology (N=164) found that a weight-based T4/T3 combination ratio of 17:1 produced the most stable serum thyroid hormone levels, though individual variation was substantial. [14]

Follow-up TSH and Free T3 testing is standard at 6 to 8 weeks after any dose change. Steady state for liothyronine is reached in approximately 4 to 7 days, but TSH suppression lags by several weeks because the pituitary responds to the integrated T3 signal over time. [5]

HealthRX T3 Prescribing Decision Framework (for editorial review and physician sign-off before publication):

Arkansas clinicians typically use a three-gate approach before initiating liothyronine:

1. Gate 1 (Diagnosis confirmed): Primary hypothyroidism documented by TSH >4.0 mIU/L at diagnosis, with current management on levothyroxine.
2. Gate 2 (Persistent symptoms despite adequate T4): TSH within range on current levothyroxine dose for at least 3 months, but Free T3 in the lower tertile of the reference range (below approximately 2.8 pg/mL) and patient-reported symptom burden score >50 on ThyPRO-39 or equivalent.
3. Gate 3 (No contraindications): No untreated adrenal insufficiency, active cardiovascular event, or TSH <0.4 mIU/L (indicating over-replacement).

Only patients clearing all three gates are typically offered liothyronine as an adjunct in a standard Arkansas endocrinology or telehealth practice.

Arkansas Pharmacy Options: Brand, Generic, and Compounded Liothyronine

Brand-Name Cytomel and Generic Tablets

Pfizer's Cytomel is available in 5 mcg, 25 mcg, and 50 mcg tablets. Generic liothyronine (multiple manufacturers) is dispensed at most Arkansas retail chains including CVS, Walgreens, Walmart Pharmacy, and Kroger Pharmacy. A 30-day supply of generic 25 mcg liothyronine typically costs $15, $40 without insurance at Arkansas pharmacies, based on GoodRx pricing data for ZIP codes in the Little Rock and Fayetteville markets.

503A Compounding Pharmacies in Arkansas

Arkansas-licensed 503A compounding pharmacies may prepare custom-strength liothyronine formulations when commercially available tablets do not meet a patient's clinical needs. A 503A pharmacy prepares patient-specific compounded drugs under a valid prescription, operating under Arkansas State Board of Pharmacy oversight and USP <797> and <795> standards. [15] Common reasons for compounding include doses below 5 mcg (needed for very slow titration in elderly or cardiac patients) and sustained-release formulations, though the FDA has not approved sustained-release liothyronine and evidence for its superiority over immediate-release is limited. [16]

Patients should verify that any Arkansas pharmacy filling a compounded liothyronine prescription holds a current Arkansas State Board of Pharmacy license. The board's public license verification tool is available at the Arkansas State Board of Pharmacy website.

Mail-Order and Out-of-State Pharmacies

Arkansas patients may also use mail-order pharmacies licensed to ship into Arkansas, including those affiliated with insurance PBMs (Express Scripts, CVS Caremark, OptumRx). Telehealth platforms that serve Arkansas often have preferred pharmacy partners who ship directly to the patient's door within 3, 5 business days of prescription transmission.

Prior Authorization for Liothyronine Under Arkansas Medicaid and Insurance

Arkansas Medicaid (Arkansas DHS Division of Medical Services) classifies liothyronine as a preferred drug with prior authorization required for most indications. As of the most recent Arkansas Preferred Drug List cycle, liothyronine requires documentation that the patient has an established diagnosis of primary or secondary hypothyroidism and has trialed levothyroxine monotherapy for at least 90 days with documented persistent symptoms. [17]

For commercial insurance plans operating in Arkansas, prior authorization requirements vary by carrier. Blue Cross and Blue Shield of Arkansas, the state's largest commercial insurer, requires a PA for liothyronine when TSH is within the normal reference range, reflecting the insurer's interpretation that normal TSH implies adequate replacement. Patients whose clinicians believe combination therapy is warranted despite normal TSH should prepare a prior authorization letter that includes:

• ICD-10 diagnosis code (E03.9 for hypothyroidism, unspecified; or E89.0 for post-procedural hypothyroidism)
• Recent lab values showing Free T3 in the lower tertile with normal TSH
• Documentation of at least 3 months on levothyroxine with persistent symptoms
• A statement that liothyronine is medically necessary per ATA or ETA guidelines [3] [4]
• Prescriber attestation to cardiovascular risk screening

The ATA's 2014 guidelines explicitly support combination therapy for a "subset of hypothyroid patients" who do not achieve satisfactory quality of life on T4 alone, and citing that language in a PA letter has supported approvals at Arkansas commercial plans. [3]

If the initial PA is denied, Arkansas law requires the insurer to provide a written reason within 14 days for non-urgent requests. The patient or prescriber may request an expedited peer-to-peer review with the plan's medical director within 72 hours of denial under Arkansas Insurance Department Rule 59. [18]

Transferring an Existing Cytomel Prescription to Arkansas

Patients who move to Arkansas from another state may transfer their liothyronine prescription to an Arkansas pharmacy if the prescription is not expired and refills remain. Arkansas pharmacy law follows the NABP Model Pharmacy Practice Act: an out-of-state prescription for a non-controlled drug may be accepted by an Arkansas pharmacist provided the original prescription was issued by a practitioner licensed in the state of origin. [19] The Arkansas pharmacist may then dispense and continue to refill within the original prescription's authorized quantity.

One common complication: if the original prescription was written by an out-of-state telehealth provider who is not licensed in Arkansas, the Arkansas pharmacist may decline the transfer. In that case, the patient must establish care with an Arkansas-licensed provider and obtain a new prescription. Most telehealth platforms that operate nationally have Arkansas-licensed clinicians on staff for exactly this purpose.

Telehealth Platforms Serving Arkansas Liothyronine Patients

Arkansas residents have access to multiple telehealth services that employ Arkansas-licensed clinicians who prescribe thyroid medications. A typical telehealth workflow for liothyronine proceeds as follows:

1. Patient submits intake form with symptom history, current medications, and uploaded lab results.
2. An Arkansas-licensed NP, PA, or physician reviews the intake asynchronously and either clears the patient for a video visit or requests additional labs.
3. A synchronous video visit (15 to 30 minutes) covers clinical history, exam findings the patient can self-report, and a prescribing decision.
4. If liothyronine is indicated, the prescription is sent electronically to a pharmacy within 24 hours of the visit.
5. The patient receives the medication in 3, 7 business days when using mail-order, or may pick up at a local Arkansas pharmacy the same day if a retail pharmacy is used.

The total timeline from first contact to having medication in hand is typically 5, 10 business days for established patients with current labs, and 10, 21 business days for new patients who need lab work before the clinical visit. [20]

Monitoring After Starting Liothyronine in Arkansas

Once a patient in Arkansas starts liothyronine, the prescribing clinician will schedule follow-up labs and a clinical check-in. Standard monitoring intervals per ATA guidance are: [3]

• 6 to 8 weeks after initiation or any dose change: TSH, Free T3, Free T4, resting heart rate
• Every 6 months once stable: TSH and Free T3 minimum; Free T4 and lipid panel annually
• Annually: bone density screening in post-menopausal women and men over 65 on long-term liothyronine, given that suppressed TSH is associated with decreased bone mineral density. A meta-analysis of 13 studies (N=2,399) published in the Journal of Clinical Endocrinology and Metabolism found that TSH suppression below 0.1 mIU/L was associated with a 1.6-fold increase in hip fracture risk. [21]

Symptoms that warrant earlier contact with the prescribing clinician include palpitations, chest pain, significant weight loss exceeding 5% of body weight within 4 weeks, or tremor. These may indicate over-replacement requiring dose reduction. [13]

Side Effects and Contraindications Patients in Arkansas Should Know

Liothyronine's side effects are largely dose-dependent and mirror symptoms of hyperthyroidism. The FDA label lists the following as the most frequently reported adverse reactions: palpitations, tachycardia, arrhythmia, angina, tremors, headache, insomnia, diarrhea, and excessive sweating. [13] Most resolve with dose reduction.

Absolute contraindications include:

• Untreated adrenal cortical insufficiency (thyroid hormone increases metabolic rate and can precipitate adrenal crisis if cortisol is already deficient)
• Apparent hypersensitivity to any component of the formulation
• Thyrotoxicosis of any etiology

Liothyronine should be used with caution in patients taking warfarin (T3 increases catabolism of vitamin K-dependent clotting factors, raising INR), diabetes medications (thyroid hormone increases glucose availability), and beta-blockers (propranolol at doses above 160 mg/day can reduce T4-to-T3 conversion by up to 30%). [13] [22]

A 2019 pharmacovigilance analysis using the FDA Adverse Event Reporting System (FAERS) identified cardiac arrhythmia as the most common serious adverse event associated with liothyronine, appearing in 18.4% of serious-event reports. [23] Arkansas prescribers use that data to reinforce the importance of ECG screening in patients over 60 before initiating therapy.

Cost and Savings Programs for Arkansas Patients

Generic liothyronine is one of the lower-cost thyroid medications. Without insurance, a 30-day supply of 25 mcg generic liothyronine averages $20, $35 at Arkansas chain pharmacies using discount programs such as GoodRx or RxSaver. Brand-name Cytomel is substantially more expensive, typically $150, $300 per month without coverage, making generic substitution the standard first step for cost-conscious patients.

Pfizer does not currently list a patient assistance program specific to Cytomel on its website, but patients meeting income criteria may qualify through NeedyMeds.org or the Partnership for Prescription Assistance. Arkansas Medicaid covers generic liothyronine with PA, as described above, effectively making the cost zero at the point of dispensing for qualifying enrollees. [17]

Arkansas residents enrolled in Medicare Part D will find that generic liothyronine is on most formularies as a Tier 1 drug, with a typical copay of $0, $10 per month. Brand-name Cytomel often falls in Tier 3 or Tier 4, with copays ranging from $45 to $100+ per month depending on the plan. Patients in the coverage gap (donut hole) in 2025 pay no more than 25% of the drug's cost after reaching the deductible, following the Inflation Reduction Act Part D restructuring that took effect January 1, 2025. [24]